Identification of BTG1 Status in Solid Cancer for Future Researches Using a System Review and Meta-analysis

Overview

Journal Curr Med Sci

Specialty General Medicine

Date 2020 Mar 14

PMID 32166669

Citations 1

Authors

Xiu-Qiong Chen

Fan-Qiao Meng

Hua Xiong

Ya-Li Wang

Wen-Hua Tang

Yan-Mei Zou

Affiliations

Soon will be listed here.

Abstract

Abundant studies have been conducted to identify how B-cell translocation gene 1 protein (BTG1) gene affects the differentiation, proliferation, metastasis of cancer cells, and how it further regulates the generation or development of diseases to influence the prognosis of patients. However, the data from single research were not powerful enough. The correlations between BTG1 expression and mechanisms of tumorigenesis or prognosis of patients are still in controversial. Our system review and meta-analysis provided a complete explanation about the association between BTG1 expression and clinicopathological features or prognosis of patients, which further laid a foundation for future research on BTG1. Fifteen eligible studies consisting of 1992 participants were included. We uncovered that BTG1 expression in solid tumors was associated with lymph node status (RR=0.66, 95% CI: 0.58-0.75, P=0.142), TMN stage status (RR=2.13, 95% CI: 1.71-2.65, P=0.001), T category (RR=1.90, 95% CI: 1.20-3.00, P=0.000), histological differentiation (RR=1.91, 95% CI: 1.55-2.37, P=0.012), vascular invasion (RR=0.90, 95% CI: 0.57-1.41, P=0.001). BTG1 low expression was significantly associated with overall survival (OS) (HR=0.47, 95% CI: 0.38-0.67, P=0.000). It concluded that BTG1 possessed the potential value for future research and could be recommended as a significant biomarker in solid tumor.

Citing Articles

The p53 Pathway Related Genes Predict the Prognosis of Colon Cancer.

Feng J Int J Gen Med. 2022; 15:169-177.

PMID: 35023955 PMC: 8747760. DOI: 10.2147/IJGM.S346280.

References

Zheng H, Li J, Shen D, Yang X, Zhao S, Wu Y . BTG1 expression correlates with pathogenesis, aggressive behaviors and prognosis of gastric cancer: a potential target for gene therapy. Oncotarget. 2015; 6(23):19685-705. PMC: 4637314. DOI: 10.18632/oncotarget.4081. View

Robin-Lespinasse Y, Sentis S, Kolytcheff C, Rostan M, Corbo L, Le Romancer M . hCAF1, a new regulator of PRMT1-dependent arginine methylation. J Cell Sci. 2007; 120(Pt 4):638-47. DOI: 10.1242/jcs.03357. View

Rouault J, Rimokh R, Tessa C, Paranhos G, Ffrench M, Duret L . BTG1, a member of a new family of antiproliferative genes. EMBO J. 1992; 11(4):1663-70. PMC: 556617. DOI: 10.1002/j.1460-2075.1992.tb05213.x. View

Zhang H, Tang J, Li C, Kong J, Wang J, Wu Y . MiR-22 regulates 5-FU sensitivity by inhibiting autophagy and promoting apoptosis in colorectal cancer cells. Cancer Lett. 2014; 356(2 Pt B):781-90. DOI: 10.1016/j.canlet.2014.10.029. View

Cortes U, Moyret-Lalle C, Falette N, Duriez C, Ghissassi F, Barnas C . BTG gene expression in the p53-dependent and -independent cellular response to DNA damage. Mol Carcinog. 2000; 27(2):57-64. View

Egger M, Davey Smith G, Schneider M, Minder C . Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997; 315(7109):629-34. PMC: 2127453. DOI: 10.1136/bmj.315.7109.629. View

Sun G, Lu Y, Cheng Y, Yang C, Liu Q, Jing S . Expression of BTG1 in hepatocellular carcinoma and its correlation with cell cycles, cell apoptosis, and cell metastasis. Tumour Biol. 2014; 35(12):11771-9. DOI: 10.1007/s13277-014-2298-x. View

Nahta R, Yuan L, Fiterman D, Zhang L, Fraser Symmans W, Ueno N . B cell translocation gene 1 contributes to antisense Bcl-2-mediated apoptosis in breast cancer cells. Mol Cancer Ther. 2006; 5(6):1593-601. DOI: 10.1158/1535-7163.MCT-06-0133. View

Tijchon E, van Emst L, Yuniati L, van Ingen Schenau D, Havinga J, Rouault J . Tumor suppressors BTG1 and BTG2 regulate early mouse B-cell development. Haematologica. 2016; 101(7):e272-6. PMC: 5004470. DOI: 10.3324/haematol.2015.139675. View

10.

Sun G, Wang Y, Cheng Y, Hu W . The expression of BTG1 is downregulated in nasopharyngeal carcinoma and possibly associated with tumour metastasis. Mol Biol Rep. 2014; 41(9):5979-88. DOI: 10.1007/s11033-014-3475-0. View

11.

Jiang R, Hu W, Sun G, Wang J, Han X . [Expression of BTG1 protein in laryngeal squamous cell carcinoma and its clinical significance]. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2015; 29(16):1447-50. View

12.

Lee H, Cha S, Lee M, Cho G, Choi W, Suk K . Role of antiproliferative B cell translocation gene-1 as an apoptotic sensitizer in activation-induced cell death of brain microglia. J Immunol. 2003; 171(11):5802-11. DOI: 10.4049/jimmunol.171.11.5802. View

13.

Vadgama J, Scuric Z, Chakrabarti R, Marzo E, Shen D, Wu Y . Insulin-like growth factor I differentially regulates the expression of HIRF1/hCAF1 and BTG1 genes in human MCF-7 breast cancer cells. Int J Mol Med. 2006; 18(1):129-39. View

14.

Cho I, Lee A, Lee S, Lee M, Kim S . Repression by oxidative stress of iNOS and cytokine gene induction in macrophages results from AP-1 and NF-kappaB inhibition mediated by B cell translocation gene-1 activation. Free Radic Biol Med. 2005; 39(11):1523-36. DOI: 10.1016/j.freeradbiomed.2005.07.017. View

15.

van Galen J, Kuiper R, van Emst L, Levers M, Tijchon E, Scheijen B . BTG1 regulates glucocorticoid receptor autoinduction in acute lymphoblastic leukemia. Blood. 2010; 115(23):4810-9. DOI: 10.1182/blood-2009-05-223081. View

16.

Suk K, Sipes D, Erickson K . Enhancement of B-cell translocation gene-1 expression by prostaglandin E2 in macrophages and the relationship to proliferation. Immunology. 1997; 91(1):121-9. PMC: 1364044. DOI: 10.1046/j.1365-2567.1997.00235.x. View

17.

Dupressoir A, Morel A, Barbot W, Loireau M, Corbo L, Heidmann T . Identification of four families of yCCR4- and Mg2+-dependent endonuclease-related proteins in higher eukaryotes, and characterization of orthologs of yCCR4 with a conserved leucine-rich repeat essential for hCAF1/hPOP2 binding. BMC Genomics. 2001; 2:9. PMC: 61044. DOI: 10.1186/1471-2164-2-9. View

18.

Sun G, Wang Y, Cheng Y, Hu W . BTG1 underexpression is an independent prognostic marker in esophageal squamous cell carcinoma. Tumour Biol. 2014; 35(10):9707-16. DOI: 10.1007/s13277-014-2245-x. View

19.

Stang A . Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010; 25(9):603-5. DOI: 10.1007/s10654-010-9491-z. View

20.

Wu X, Ding N, Hu W, He J, Xu S, Pei H . Down-regulation of BTG1 by miR-454-3p enhances cellular radiosensitivity in renal carcinoma cells. Radiat Oncol. 2014; 9:179. PMC: 4252025. DOI: 10.1186/1748-717X-9-179. View